Literature DB >> 8739332

I/D polymorphism at the locus for ACE and apo A-I gene promoter polymorphism as risk factors for coronary artery disease in patients with familial hypercholesterolemia.

D Petrovic1, I Kleber, M Zorc, B Peterlin.   

Abstract

In our study we searched for an association between the insertion/deletion (I/D) polymorphism at the ACE locus as well as apo A-I promoter polymorphism and coronary artery disease (CAD) in patients with familial hypercholesterolemia (FH). 34 FH patients over 40 years were ascertained; 16 patients with CAD were compared with 18 patients without CAD. There was an excess of DD or ID genotype in FH patients with CAD (OR = 4.9, CI = 1.17-22.17; Fisher exact p = 0.012), however, no association between G to A substitution in the promoter region of the apo A-I gene and CAD was found. Our results suggest that the DD/ID genotype at the ACE gene locus might be an important genetic risk factor for CAD in FH patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739332     DOI: 10.1007/bf02346336

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  7 in total

1.  Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI.

Authors:  P S Hansen; N Rüdiger; A Tybjaerg-Hansen; O Faergeman; N Gregersen
Journal:  J Lipid Res       Date:  1991-07       Impact factor: 5.922

2.  Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics.

Authors:  R R Williams; S C Hunt; M C Schumacher; R A Hegele; M F Leppert; E H Ludwig; P N Hopkins
Journal:  Am J Cardiol       Date:  1993-07-15       Impact factor: 2.778

3.  Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction.

Authors:  L Tiret; F Kee; O Poirier; V Nicaud; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; P Amouyel
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

Review 4.  Lipoprotein(a). A genetic risk factor for premature coronary heart disease.

Authors:  A M Scanu
Journal:  JAMA       Date:  1992-06-24       Impact factor: 56.272

5.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.

Authors:  F Cambien; O Poirier; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; J M Bard; L Bara; S Ricard
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

6.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

7.  G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations.

Authors:  M Jeenah; A Kessling; N Miller; S Humphries
Journal:  Mol Biol Med       Date:  1990-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.